MAGDALENA CZAJKA: Open Payments
NPI 1598469181 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 65 payments from 30 companies in 2025. Trend: 2023 $661 · 2024 $2,917 · 2025 $1,655
Food & beverage: $1,299Education: $356
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $402 |
| Sumitomo Pharma America, Inc. | 13 | $278 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $83 |
| Janssen Biotech, Inc. | 3 | $65 |
| Amgen Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| ABBVIE INC. | 3 | $61 |
| Lilly USA, LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $49 |
Products named: GEMTESA, ORGOVYX, Nubeqa, ERLEADA, JARDIANCE, KEYTRUDA, OTEZLA, LUPRON DEPOT.
Industry payments across CO — which companies pay providers there.
